182 related articles for article (PubMed ID: 31102498)
1. Rituximab as Maintenance Treatment for Systemic Lupus Erythematosus: A Multicenter Observational Study of 147 Patients.
Cassia MA; Alberici F; Jones RB; Smith RM; Casazza G; Urban ML; Emmi G; Moroni G; Sinico RA; Messa P; Hall F; Vaglio A; Gallieni M; Jayne DR
Arthritis Rheumatol; 2019 Oct; 71(10):1670-1680. PubMed ID: 31102498
[TBL] [Abstract][Full Text] [Related]
2. Rituximab as maintenance therapy following remission induction in relapsing or refractory systemic lupus erythematosus.
Chen X; Shi X; Xue H; Lv H; Yu L; Wu X; Wang Q; Wu H; Han F; Xue J
Rheumatology (Oxford); 2023 Mar; 62(3):1145-1152. PubMed ID: 35976105
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and Safety of Rituximab in Systemic Lupus Erythematosus: A Case Series Describing the Experience of 2 Centers.
Gómez VJ; Carrión-Barberá I; Salman Monte TC; Acosta A; Torrente-Segarra V; Monfort J
Reumatol Clin (Engl Ed); 2020; 16(5 Pt 2):391-395. PubMed ID: 30522941
[TBL] [Abstract][Full Text] [Related]
4. Rituximab as add-on therapy in patients with resistant lupus nephritis who have failed induction or maintenance therapy with other agents: A real-world experience from a single center in Mumbai.
Yadav S; Balakrishnan C; Mangat G; Kothari J
Lupus; 2024 Jan; 33(1):88-95. PubMed ID: 38048588
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of rituximab for systemic lupus erythematosus-associated immune cytopenias: A multicenter retrospective cohort study of 71 adults.
Serris A; Amoura Z; Canouï-Poitrine F; Terrier B; Hachulla E; Costedoat-Chalumeau N; Papo T; Lambotte O; Saadoun D; Hié M; Blanche P; Lioger B; Gottenberg JE; Godeau B; Michel M
Am J Hematol; 2018 Mar; 93(3):424-429. PubMed ID: 29247540
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Rituximab in Systemic Lupus Erythematosus and Sjögren Syndrome Patients With Refractory Thrombocytopenia: A Retrospective Study of 21 Cases.
Jiang B; Li T; Guo L; Shen H; Ye S; Chen S
J Clin Rheumatol; 2015 Aug; 21(5):244-50. PubMed ID: 26203828
[TBL] [Abstract][Full Text] [Related]
7. Anti B-cell therapy against refractory thrombocytopenia in SLE and MCTD patients: long-term follow-up and review of the literature.
Jovancevic B; Lindholm C; Pullerits R
Lupus; 2013 Jun; 22(7):664-74. PubMed ID: 23612795
[TBL] [Abstract][Full Text] [Related]
8. Rituximab use in pediatric systemic lupus erythematosus: Indications, efficacy and safety in an Indian cohort.
Sawhney S; Agarwal M
Lupus; 2021 Oct; 30(11):1829-1836. PubMed ID: 34315295
[No Abstract] [Full Text] [Related]
9. Use of Rituximab in Systemic Lupus Erythematosus: A Single Center Experience Over 14 Years.
Aguiar R; Araújo C; Martins-Coelho G; Isenberg D
Arthritis Care Res (Hoboken); 2017 Feb; 69(2):257-262. PubMed ID: 27110698
[TBL] [Abstract][Full Text] [Related]
10. The retrospective evaluation of efficacy and safety data after switching from originator rituximab to biosimilar rituximab (CT-P10) in patients diagnosed with systemic lupus erythematosus: a single-center experience.
Ekin A; Mısırcı S; Coşkun BN; Yağız B; Dalkılıç E; Pehlivan Y
Eur Rev Med Pharmacol Sci; 2024 May; 28(10):3513-3522. PubMed ID: 38856126
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitis.
Alberici F; Smith RM; Jones RB; Roberts DM; Willcocks LC; Chaudhry A; Smith KG; Jayne DR
Rheumatology (Oxford); 2015 Jul; 54(7):1153-60. PubMed ID: 25477054
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French AutoImmunity and Rituximab registry.
Terrier B; Amoura Z; Ravaud P; Hachulla E; Jouenne R; Combe B; Bonnet C; Cacoub P; Cantagrel A; de Bandt M; Fain O; Fautrel B; Gaudin P; Godeau B; Harlé JR; Hot A; Kahn JE; Lambotte O; Larroche C; Léone J; Meyer O; Pallot-Prades B; Pertuiset E; Quartier P; Schaerverbeke T; Sibilia J; Somogyi A; Soubrier M; Vignon E; Bader-Meunier B; Mariette X; Gottenberg JE;
Arthritis Rheum; 2010 Aug; 62(8):2458-66. PubMed ID: 20506527
[TBL] [Abstract][Full Text] [Related]
13. Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener's). Results of a single-center cohort study on 66 patients.
Calich AL; Puéchal X; Pugnet G; London J; Terrier B; Charles P; Mouthon L; Guillevin L;
J Autoimmun; 2014 May; 50():135-41. PubMed ID: 24703438
[TBL] [Abstract][Full Text] [Related]
14. Brief Report: Rituximab for the Treatment of Adult-Onset IgA Vasculitis (Henoch-Schönlein).
Maritati F; Fenoglio R; Pillebout E; Emmi G; Urban ML; Rocco R; Nicastro M; Incerti M; Goldoni M; Trivioli G; Silvestri E; Mohammad AJ; Jayne D; Eriksson P; Segelmark M; Novikov P; Harris H; Roccatello D; Vaglio A
Arthritis Rheumatol; 2018 Jan; 70(1):109-114. PubMed ID: 28973844
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of rituximab therapy for 10 patients suffering from systemic lupus erythematosus with intestinal involvement].
Zhao YR; Zhao Z; Zhang J; Li KP; Yang JS; Sun F; Liao SM; Zhang JL; Huang F; Zhu J
Zhonghua Nei Ke Za Zhi; 2024 Feb; 63(2):198-202. PubMed ID: 38326047
[TBL] [Abstract][Full Text] [Related]
16. Rituximab with or without a conventional maintenance agent in the treatment of relapsing granulomatosis with polyangiitis (Wegener's): a retrospective single-center study.
Azar L; Springer J; Langford CA; Hoffman GS
Arthritis Rheumatol; 2014 Oct; 66(10):2862-70. PubMed ID: 24943239
[TBL] [Abstract][Full Text] [Related]
17. [Rituximab therapy for severe pediatric systemic lupus erythematosus].
Su GX; Wu FQ; Wang F; Zhou ZX; Huang XL; Lu J
Zhonghua Er Ke Za Zhi; 2012 Sep; 50(9):697-704. PubMed ID: 23158822
[TBL] [Abstract][Full Text] [Related]
18. Maintenance treatment of pemphigus with rituximab in real life: A single-center study of 50 patients.
Louchez A; El Aarbaoui T; Weill A; Gaudin O; Jelti L; Belmondo T; Wolkenstein P; Ingen-Housz-Oro S
Ann Dermatol Venereol; 2024 Jun; 151(2):103264. PubMed ID: 38537431
[TBL] [Abstract][Full Text] [Related]
19. Rituximab in children with steroid-dependent nephrotic syndrome: experience of a tertiary center and review of the literature.
Van Horebeek I; Knops N; Van Dyck M; Levtchenko E; Mekahli D
Acta Clin Belg; 2017 Jun; 72(3):147-155. PubMed ID: 27409338
[TBL] [Abstract][Full Text] [Related]
20. Rituximab Induction and Maintenance Treatment in Patients with Scleritis and Granulomatosis with Polyangiitis (Wegener's).
You C; Ma L; Lasave AF; Foster CS
Ocul Immunol Inflamm; 2018; 26(8):1166-1173. PubMed ID: 28628344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
